Telik, Inc. (TELK)
$0.79
-0.03 (-3.66%)
| CAPS Rating |
|
|---|---|
| Open | $0.84 |
| Previous Close | $0.82 |
| Daily Range | $0.78 - $0.84 |
| 52-Week Range | $0.16 - $1.40 |
| Market Cap | $42.15M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 393,595 |
| Average Daily Volume | 292,000 |
TELK
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
TELK Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
TELK News and Commentary
- Telik says early-stage trial data of lung cancer drug positive – Reuters
- Closing TELK (Telik) underperform – Blog at The Motley Fool
- Worst Stock for 2008: Pfizer – The Motley Fool
- Biogen Can't Find a Buyer – The Motley Fool
- Neurochem's Crazy Choice – The Motley Fool
- 7 Surprising 1-Star Stocks – The Motley Fool
- World's Scariest Stock: Dendreon – The Motley Fool
- A Surprising Decision for Telik – The Motley Fool
- Following the Fallen Biotech Class of 2006 – The Motley Fool
- More Misery for Neurochem – The Motley Fool
- Get Ready for the Bounce – The Motley Fool
- Here Come the Dendreon Lawsuits – The Motley Fool
- Is Telik Insane? – The Motley Fool
Related News and Articles
- This Top Stock Is a Winner – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Finally Convinced? Benlysta Works! – The Motley Fool
RSS Headlines
Fool UK
